PARP Inhibitor Market is Estimated to Witness High Growth Owing to...

adicionou um novo artigo Health

2024-01-03 11:07:23 -

PARP Inhibitor Market is Estimated to Witness High Growth Owing to Increasing Adoption in Oncology Treatment

Market Dynamics Increasing adoption in oncology treatment: The key driver for the growth of the PARP inhibitor market is its increasing adoption in the treatment of various cancers like breast and ovarian cancers. As per the National Cancer Institute, PARP inhibitors have shown promising results in slowing or stopping the growth of cancer cells with BRCA1 or BRCA2 gene mutations. This is...

0 Comentários 0 Compartilhamentos 1K Visualizações 0 Anterior